BIRC5 and urinary bladder carcinoma: In patients with bladder cancer, there is no common threshold value in defining positive expression of survivin, but it is important that a common or standard threshold in the assessment of some biomarker should be set to make a comparatively accurate evaluation of its real function in clinical practice.